| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.1 | 0.5 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.1 | 0.5 |